For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
Blog
This week in health care policy: October 8–15, 2026
Innovation watch Merck expects faster production of its personalized cancer vaccine. CEO Rob Davis told CNBC the six-week turnaround for…
Blog
This week in health care policy: October 5–9, 2026
Drug pricing and 340B PhRMA sues to block GLOBE. On October 7, PhRMA sued to block the most-favored-nation drug-pricing model…
Blog
New legislation seeks to shuffle the deck chairs on the sinking No Surprises Act
On October 8, Rep. Frank Pallone (D-NJ) introduced the Lower Premiums, Faster Payments Act as a fix for the disastrous No Surprises Act (NSA).
Search Posts
Citation
The Anti-GM Food Circus Rolls Through Connecticut
From the American Council on Science and Health’s “Health Facts and Fears”: But as Gregory Conko, a senior fellow at the Competitive Enterprise…
Blog
Taxmageddon Comes Just After the Election
On December 31, shortly after the November election, tax rates will rise across the board in what congressional aides call "Taxmageddon," notes The Washington Post. Not…
Op-Eds
Shoppers already have a choice regarding biotech foods
Consumers increasingly base food purchasing decisions on individual preferences about product content. For many, this means a focus on nutrition or fat. Others care more…
Blog
CEI Podcast for February 16, 2012: Washington’s Prescription Drug Shortage
Patients are suffering from a nationwide shortage of more than 260 different prescription drugs, many of them for different types of cancer. Senior Fellow Greg…
Blog
Congress Seems Intent on Making Drug Shortages Worse
Now that the problem of prescription drug shortages has begun to affect children, members of Congress want to be seen as…
Op-Eds
How is the FDA Really Doing?
I read with interest—and mounting skepticism—Patricia Dimond’s Insight & Intelligence™ piece about FDA, “FDA New Drug Approvals in 2011 Outpace…